Načítá se...
Hypokalemia secondary to capecitabine: a hidden toxicity?
BACKGROUND: Hyopkalemia is a listed toxicity in the capecitabine (Xeloda®; Roche, Nutley, NJ) package insert. However, the incidence and severity of this toxicity is not known. METHODS: We performed a retrospective evaluation of hypokalemia in 77 patients, who received capecitabine for gastrointesti...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936298/ https://ncbi.nlm.nih.gov/pubmed/18360625 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|